Prime Minister invests €10 million in animal-based business alongside farmers' alliance
In a significant development for the European farming sector, Belgian biotech company Animab has developed an antibody named Nanoprotec to combat gastrointestinal infections in pigs. This innovative product, which targets enterotoxigenic Escherichia coli (ETEC F4), a leading cause of diarrhoea in piglets, is set to offer farmers an antibiotic-free alternative to current medication.
The investment community has shown confidence in Animab's solution, with the company securing €10 million in funding from PMV, AIF, QBIC, Seventure Partners, and Laboratory group Anacura. Kenneth Wils, head of life sciences and care at PMV, considers Animab's innovation to be revolutionary and exactly the type of innovation the European farming sector needs.
Felix Van Camp, a business strategist at Anacura, expressed similar enthusiasm about investing in Animab. He cited the proven credibility of Animab's leadership as a factor in the investment decision, as well as the strength of Nanoprotec and Animab's promising pipeline.
The product, given to piglets in their drinking water, prevents bacterial adhesion to the intestinal wall, neutralising potentially harmful pathogens. The European Union backs Animab under its InvestEU programme.
As for the commercial launch and regulatory approval timeline for Nanoprotec, there is no publicly available information from search results regarding these details. However, Animab has announced that Nanoprotec will be sent to the European Medicines Agency for regulatory submission before the end of this year, with a product launch planned for the end of 2026.
The funding secured by Animab will be used for the commercial launch of the oral antibody and the advancement of its product pipeline. The investment comes at a critical time, as antimicrobial resistance, which may lead to 22 million deaths annually by 2050, poses a rising threat to global public health.
For those seeking detailed and up-to-date information about Nanoprotec's approval process and launch schedule, it is recommended to check Animab's official announcements, their website, industry press releases, or veterinary pharmaceutical regulatory filings.
Read also:
- Connection Between ADHD and Trauma?
- West Nile Virus detected in Kentucky for the first time; authorities advise locals to adopt safety measures
- Digestive issues: Understanding causes, remedies, and further details about acid reflux and excessive burping
- Exploring Botox as a Treatment for Interstitial Cystitis: Insights, Adverse Effects, and Further Details
